Presentation is loading. Please wait.

Presentation is loading. Please wait.

Pediatric Chronic Abdominal Pain John F. Pohl MD Professor of Pediatrics Primary Children’s Medical Center University of Utah Salt Lake City, Utah.

Similar presentations


Presentation on theme: "Pediatric Chronic Abdominal Pain John F. Pohl MD Professor of Pediatrics Primary Children’s Medical Center University of Utah Salt Lake City, Utah."— Presentation transcript:

1 Pediatric Chronic Abdominal Pain John F. Pohl MD Professor of Pediatrics Primary Children’s Medical Center University of Utah Salt Lake City, Utah

2 Disclosure: INSPPIRE to Study Acute Recurrent and Chronic Pancreatitis in Children, NIH R21 Grant, NIDDK

3 Learning Objectives  Understand the physiology and differential diagnosis of chronic abdominal pain in children.  Understand the testing (laboratory, radiographic, endoscopic) available for the treatment of chronic abdominal pain in children.  Understand the treatment options for chronic abdominal pain, including treatment for recurrent abdominal pain of childhood and irritable bowel syndrome.

4 Somatic Complaints in Our Practice  IBS  Chronic pelvic pain  Interstitial cystitis  Fibromyalgia  Certain headache presentations 38-60% of visits to the primary care office practice! Kroenke, et al. Am J Med (1989): Only 16% of 1000 general medical outpatients had an organic cause to somatic complaints.

5 Somatic Complaints in Our Practice  Just because no organic source for a complaint is found, this does not rule out neurobiological alterations.  Regardless, many of us feel this way: “A patient has irritable bowel syndrome if your stomach hurts after you leave the patient’s room…”

6 How Common in Pediatric Abdominal Pain?  Survey of 500 adolescents in a community clinic.  13-17% experienced weekly abdominal pain  20% of these cases severe enough to affect daily activities.  Need to consider medical, social, cultural, familial, and emotional factors during evaluation. Thiessen. Recurrent abdominal pain. PIR, 2002; Vol. 23: pp

7 IBS -- History  First described by Cummings in 1849 (London Med Gazette).  Various terms used: Spastic colon, nervous colon, irritable colon, “colitis”  Defined by the Rome criteria: 1.12 week (or more) history in a 12 month period of time of abdominal pain that cannot be explained by structural / biochemical abnormalities. 2.Pain is relieved with defecation. 3.Pain is associated with BM frequency change. 4.Pain is associated with BM form change. Need 2 of 3 features.

8 Separate like nuts Sausage shaped but lumpy Like a sausage but with cracks Like a snake, smooth and soft Soft blobs with clear cut edges Fluffy with ragged edges This is the only scale validated for determining diarrhea in a toilet (6 or 7)

9 In children, the presentation of IBS can appear differently AND all functional abdominal pain may not be IBS!

10 Diagnosis  History and physical examination are the cornerstone to establishing a clear diagnosis!!!  Can take at least 1 hour to completely work-up childhood abdominal pain.  Therefore, many children are sent to the pediatric gastroenterolgist due to PCP time restraints.  BUT most causes can be determined by the primary care provider.

11 Diagnosis Most referrals to the pediatric gastroenterologist: 1.Symptomatic for 12 months or less. 2.Multiple diagnostic tests (laboratory and radiographic) have already been performed by PCP. 3.Large number of negative tests reinforces parental / patient anxiety as to cause of abdominal pain (Glass-half full vs. Glass-half empty).

12 Pathophysiology of IBS…Potential Pathway Motility Disturbance? Visceral Hypersensitivity? Psychosocial factor? 1.Neurotransmitter imbalance 2.Infection 3.Inflammation Horwitz and Fisher, NEJM (2001) Hypothesis:

13 Pathophysiology of IBS…Potential Pathway Motility Disturbance? Visceral Hypersensitivity? Psychosocial factor? 1.Neurotransmitter imbalance 2.Infection 3.Inflammation Horwitz and Fisher, NEJM (2001) Rectal balloon distention of IBS patients MRI / PET changes at thalamus and anterior cingulate cortex CNS defect?

14 Ascending Aminergic System EMOTIONAL MOTOR SYSTEM Neuroendocrine Pain Modulation Autonomic CNS Defect Mechanism?

15 Bowel Motility Alteration?  Bowel motility is altered with stress.  May increase / decrease colon contraction.  Fasting (anorexia?)  loss of MMC complexes in IBS patients.  Increased contraction after high-fat meal in IBS patients.

16 ARM

17 ARM ARM External sphincter Internal sphincter

18 ARM

19 ARM

20 Visceral Hypersensitivity?  Balloon distention of rectum  IBS patients experience pain with smaller balloon volumes compared to controls.  WHY? Two ideas: 1.Are the pain receptors in this region “primed” by infection, lumen contents, etc? 2.Are there inherent pain modulation differences in nociceptor regions in these patients (i.e., genetic predisposition)?

21 Visceral Hypersensitivity? Faure and Wieckowska. J Peds (2007): Looked at children with IBS, FAP, Functional dyspepsia, and no symptoms. Noted significantly decreased threshold for pain sensation with polyvinyl bag.

22 Visceral Hypersensitivity? No difference P<0.002 compared to controls

23 Psychosocial factors  Stress affects bowel motility.  Patients with IBS  higher rate of psychiatric disease.  Childhood history of abuse  ↑ severity of IBS symptoms.  Noxious stimuli after birth (gastric suctioning)? Anand KJS, Runeson B, Jacobson B. “Gastric Suction at Birth Associated with Long-Term Risk for Functional Intestinal Disorders in Later Life.” The Journal of Pediatrics, 2004; Vol. 144, pp

24 Neurotransmitter Imbalance?  95% of body serotonin in the GI tract.  Serotonin enhances intestinal secretion, peristalsis (nausea, vomiting, abdominal pain, etc.).  Other transmitters involved? Acetylcholine Substance P Nitric oxide Vasoactive intestinal peptide etc…

25 Anxiety and Sensorimotor Function  Geeraerts, et al. (Gastroenterology 2005):  Took 14 patients and placed them in an anxious emotional state (anxious face minute audiotape of stressful event).  Evaluated gastric sensitivity and accommodation. Gerrarets, et al. “Influence of Experimentally Induced Anxiety on Gastric Sensorimotor Function in Humans.” Gastro 2005; 129:

26 Anxiety and Sensorimotor Function During anxiety induction:  Gastric compliance was decreased compared to controls.  Balloon volume to cause gastric discomfort decreased compared to controls.  Suggests a psychological component for pain. Gerrarets, et al. “Influence of Experimentally Induced Anxiety on Gastric Sensorimotor Function in Humans.” Gastro 2005; 129:

27 Infection / Inflammation?  Inflammatory mediators  ↑ intestinal motility  ?infectious enteritis  ↑ risk of developing IBS  Increased risk of IBS in patients with IBD (Crohn’s, Ulcerative colitis).

28 Infection / Inflammation? Mearin,et al. Gastroenterology 2005; 129:  Shigella enteritidis outbreak occurred in Catalonia, Spain (1243 persons).  Prospective evaluation of IBS symptoms in these people over time.  Followed for one year (controls vs. infected patients): 1.Dyspepsia incidence ↑’d in affected patients. 2.IBS (diarrhea-type) ↑’d in affected patients. 3.Is this an immune response? 4.Also, patients who were treated with antibiotics had a higher rate of post- infectious IBS… The reason for this is unknown. 1.Genetic tendency? 2.↑ IL-1 (pro-inflammatory)? 3.  IL-10 (antiinflammatory)?

29 Infection / Inflammation? Do pediatric patients with IBS have specificmicrobiomes? Ruminococcus-like microbe seen in pediatric patients using metagenomic PhyloChip DNA hybridization Saulnier, et al. Gastroenterology 2011 Do antibiotics work for IBS (diarrhea type) Example: Rifaximin Krause, et al. NEJM 2011

30 Diagnosis of IBS 1. Rule out the “Red Flags” of the History 2. Rule out the “Red Flags” of the Physical Exam Thiessen, Peds in Review, 2002

31 Red Flags during the History  Pain LOCALIZES away from the umbilicus.  Pain associated with bowel habit changes.  Pain with nighttime wakening.  Repetitive emesis (esp. bloody / bilious)  Constitutional symptoms: fever, weight loss  Emesis with unusual headaches (occipital) Thiessen, Peds in Review, 2002

32 Where is the Pain? RUQ 2.Epigastric 3.LUQ 4.RLQ 5.Peri-umbilical 6.LLQ 7.Suprapubic

33 Where is the Pain?  RUQ – gallstones, liver disease  Epigastric – ulcer, pancreatitis  LUQ – renal (UPJ obstruction)  RLQ – appendicitis, infectious enteritis  Periumbilical – RAP  LLQ – constipation, colitis, proctitis  Suprapubic – UTI

34 Red Flags during the P.E.  Loss of weight / decreased height velocity  Organomegaly / abdominal mass  Localized abdominal tenderness away from umbilicus.  Peri-rectal changes  Joint swelling or tenderness  Unusual rash  Pale mucosa / conjunctivae Thiessen, Peds in Review, 2002

35 Pertinent Tests Laboratory tests:  CBC, ESR  Liver panel, GGT  Amylase, lipase  UA, urine culture   -HCG  T4 / TSH  Anti-endomysial Antibody  Tissue transglutaminase Antibody (celiac testing) Radiographic tests:  Abdominal flat plate  Abdominal US  Abdominal CT  UGI ± SBFT

36 Pertinent Tests Laboratory tests:  CBC, ESR  Liver panel, GGT  Amylase, lipase  UA, urine culture   -HCG  T4 / TSH  Anti-endomysial Ab  Tissue transglutaminase Ab Radiographic tests:  Abdominal flat plate  Abdominal US  Abdominal CT  UGI ± SBFT ENDOSCOPY WITH BIOPSY?

37 What other functional abdominal pain disorders exist in children? +

38 Functional Pain (“irritable bowel syndrome”) Keep in Mind:  In 90-95% of children, no cause for abdominal pain is ever found (functional pain).  Is the pain RAP or IBS? IBS RAP

39 Functional Pain (“irritable bowel syndrome”)  Is this RAP?  Recurrent abdominal pain (RAP)  Apley (1958) had 1 st description.  Defined as 3 episodes of pain that interfere with activity in a period ≧ 3 months.  Incidence: 10-15% of children  Slightly increased prevalence in girls.

40 Functional Pain (“irritable bowel syndrome”)  Study of 1000 school children:  RAP: Boys = girls until 9 years of age.  After 9 years of age, girls > boys (1.5 : 1)  RAP rare before age 5.

41 RAP  No organic cause  Usually peri-umbilical  Self-limited  Rarely related to meals  Rarely awakens child from sleep.  “Organicity of pain is inversely proportional to the number of school absences.”

42 Irritable Bowel Syndrome (IBS)  RAP may develop into IBS.  Some children develop IBS without RAP.  Criteria for IBS: 1.Abd. pain relieved with defecation. 2.↑d stooling at onset of pain. 3.Alteration of stool form at time of pain 4.Passage of mucus 5.Associated bloating / abdominal distention 6.No pathological cause (pain fiber dysfunction?) But can see constipation or a “mixed type.”

43 Functional Pain (“irritable bowel syndrome”) PAIN Organic disease (10-15%) Psychological Stressors (family, home) Inherent stress of child (controversial) “Functional” pain (no clear cause)

44 Imaging in IBS

45 Constipation

46 Malrotation

47 Small Bowel Follow Through Ileal stricture

48 Abdominal CT Ileocecal Thickening

49 Peri-Rectal Abscess

50 Irritable Bowel Syndrome

51 H. Pylori Gastritis

52 Duodenum Lymphoid aggregate Increased inflammatory cells in crypt region

53 Shortened villi

54 Okay, you think the patient has IBS…  Treatment options:  Depends on the type of IBS… IBS Predominantly pain Constipation type Diarrhea type “Mixed”

55 IBS Treatment Placebo effect:  Can improve IBS symptoms in 20-50% of IBS patients  Thus, careful clinical trials are needed Psychotherapy:  Good for recognizing triggers of IBS.  Cognitive behavioral therapy, relaxation therapy, hypnotherapy, etc.  Mainly effects pain and diarrhea, not constipation.

56 IBS Treatment – Constipation Fiber supplementation:  Fiber  colonic bacteria utilization  increases gas/fluid  soft and wet stools  End-result: Increases peristalsis and decreases pain of defecation. # grams of fiber daily = Age + 5 (to max of grams daily)

57 IBS Treatment – Constipation Osmotic laxatives – best to use if fiber is not helping or is causing bloating.  Long-term use of osmotic laxatives are safe. 1.Milk of Magnesia ™ 2.Mineral oil (CAREFUL: aspiration pneumonia) 3.Lactulose 4.Miralax ™ (Polyethylene glycol powder 3350) – One tbsp (17g) in 8 ounces water/juice  Can be given as scheduled dosing or prn.

58 IBS Treatment – Constipation  Miralax: Pediatric dosing?  Average long term effective dose (avg. 8.4 months) has been determined to be 0.7 g/kg/day to 1 g/kg/day).  Biggest issue  Under-dosing or not using long enough. Pashankar, et al. Long-term efficacy of polyethylene glycol 3350 for the treatment of chronic constipation in children with and without encopresis. Clin Pediatr 2003; 42: Pashanker, et al. Efficacy and optimal dose of daily polyethylene glycol 3350 for treatment of constipatoin and encopresis in children. JPGN 2001; 139:

59 IBS Treatment – Constipation Stimulants (senna, bisacodyl)  I rarely use these…  Side effects: severe cramping, “dependence”, tachyphylaxis.  Animal models  possible permanent disruption of enteric nervous system. Bottom line…stick with osmotic laxatives.

60 IBS Treatment – Constipation

61 IBS Treatment – Diarrhea Opiate analogues work great!  Loperamide controls diarrhea symptoms but does NOT control pain.  No prescription needed.  Given as scheduled or prn.  Cholestyramine  good for refractory diarrhea  Antibiotics? (metronidazole, rifaximin, gentamicin) Careful of fat-soluble vitamin malabsorption!

62 IBS Treatment – Pain Antispasmodics:  Usually anticholinergic agents.  Also, can be Ca ++ -channel blockers, opiate antagonists.  Good for post-prandial increased contractility.  Studies for these agents show good results (many studies lack blinding and are short duration).

63 IBS Treatment – Pain Antispasmodics (Anticholinergics):  Often given 30 minutes prior to a meal or every 4 hours prn.  Side effects: 1.Dry mouth 2.Constipation 3.Blurred vision 4.Fatigue 5.Urination difficulty 6.Narrow-angle glaucoma and urine retention are contraindications. Sedative aspects of combining antispasmodics with sedatives or BZDs may decrease anxiety aspects of IBS.

64 Antispasmodic Agents Single agents:  Belladona  Hyoscyamine (Levsin®)  Glycopyrrolate (Robinul®)  Dicyclomine (Bentyl®)  Clidinium Combined agents:  Clidinium + chlordiazepoxide (Librax®)  Hyoscyamine + atropine + phenobarbital (Donnatal®) Risk of addictive effects low when combined with unpleasant effects of high-dose anticholinergics..

65 Tricyclic Antidepressants  Ex. Amitriptyline, nortriptyline  Effective at low doses for migraine, neuropathic pain,noncardiac chest pain, IBS.  May ↑ visceral pain threshold.  At low dosing, no anti-depressant effects noted.  Effects takes 1-2 weeks.  Effect may be anticholinergic. Serotonergic effects unknown.  May work best for diarrhea-predominant IBS.

66 Tricyclic Antidepressants  Side effects: 1.Fatigue 2.Somnolence 3.Dry mouth 4.Urinary retention 5.Rare: cardiac arrhythmia, lowered seizure threshold.  Start at low dosing (ex. Amitriptyline mg nightly). I get a baseline EKG.

67 Selective Serotonin-Reuptake Inhibitors (SSRIs)  Tried for IBS but mixed results.  Treats depression well; minimal effect on visceral pain threshold.  Best case scenario  IBS + underlying mood disorder.

68 Serotonin-3-Receptor Antagonists  Serotonin-3 receptors: ↑ intestinal motility, secretion, sensation.  Antagonist  Good for diarrhea-predominant IBS. Alosetron (Lotronex®)  2 large studies in ADULT females: good for diarrhea-predominant IBS at 1 mg bid.  Side effect: Ischemic colitis (1:700). Removed from market.  2002: FDA allowed drug back in market with strict guidelines.

69 Serotonin-4-Receptor Agonists  Serotonin-4 receptors: Increase peristalsis, increase gastric emptying. Tegaserod (Zelnorm®)  3 large ADULT studies  effective for constipation-predominant IBS for up to 12 weeks.  2 & 6 mg tabs; 6 mg po bid.  $$$. So, consider laxatives or fiber first.

70 Other Agents:  Linaclotide: Activates guanylate cyclase-C (stimulating cGMP production  fluid secretion). Contraindicated in children less than 6 years old (killed mice pups).  Lubiprostone: Activates chloride channel activation increasing fluid secretion.

71 Other Agents:  Herbal mixtures (standardized 20+ Chinese herbs)  Slight improvement in pain?  Peppermint oil: Works as an antispasmodic but also  LES sphincter tone (GERD?)  Leuprolide (gonadotropin-releasing-hormone antagonist): studied for menstrual-related IBS in women.  Buspirone: Helpful for non-ulcer dyspepsia

72 Probiotics? O’Mahony, et al., Gastroenterology 2005; 128:  Gave 77 patients (adults) with IBS either Lactobacillus salivarius or Bifidobacterium infantis.  B. infantis  improved pain, bloating, dyschezia.  No change in bowel frequency.  IL-10 / IL-12 ratio improved on therapy (↑IL-10 protective;  IL-12 protective).  Treatment for IBS?  Data for children? “Lactobacillus and Bifidobacterium in Irritable Bowel Syndrome Symptom Response and Relationship to Cytokine Profiles” Gastro 205; 128:

73 Functional Pain (“irritable bowel syndrome”) Treatment:  Exercise  Fiber (age + 5 = # of grams daily) IBS w/o change in BMs IBS with constipation IBS with diarrhea 1.Anti-spasmodic 2.TCA 3.SSRI 1.Anti-spasmodic / TCA 2.Miralax™ (polyethylene glycol) 3.Lactulose 4.Tegaserod™ (Zelnorm) 1.Anti-spasmodic / TCA 2.Loperamide 3.Antibiotics Endoscopy?

74 Cases 1.5 year old male with 6 week history of peri- umbilical pain that does not awaken at night with recent social stress year old female with 10 year history of constipation, diffuse abdominal pain, worsening now that she lives in a dorm year old male with abdominal pain in a “band”, diarrhea, and pain relief with defecation.

75 Cases 1.Counseling regarding stress, PPI?, antispasmodic, supportive care due to limited nature of disorder. 2.Osmotic laxative, fiber, tegaserod? 3.Anti-spasmotic, tricyclic, loperamide.

76 Thank you!


Download ppt "Pediatric Chronic Abdominal Pain John F. Pohl MD Professor of Pediatrics Primary Children’s Medical Center University of Utah Salt Lake City, Utah."

Similar presentations


Ads by Google